The famous quote “Those who fail to learn from history are doomed to repeat it” seems appropriate when describing the pharmaceutical industry, at least according to our track record over the last few decades. It often feels like Groundhog Day, and we are Bill Murray hitting the alarm clock before realizing “Oh, here we go again!”
Recent findings from Medidata Trial Assurance highlight the power of machine learning algorithms and their impact on pharmaceutical companies seeking greater capabilities to ensure data quality.
A TED talk about drone technology sparked a thought: will drones reshape clinical trials and the patient experience?
What are some of the metrics that can be useful for risk-based monitoring?